Chethana Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-10-2024
- Paid Up Capital ₹ 0.10 M
as on 27-10-2024
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.82%
(FY 2023)
- Profit 26.10%
(FY 2023)
- Ebitda 96.34%
(FY 2023)
- Net Worth -43.22%
(FY 2023)
- Total Assets 12.25%
(FY 2023)
About Chethana Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen, Siddharth Upadhyay, and Kaushik Natesan serve as directors at the Company.
- CIN/LLPIN
U51909KA2020PTC133694
- Company No.
133694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2020
- Date of AGM
04 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Belgaum, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Chethana Pharma Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen  | Director | 09-Feb-2022 | Current |
| Siddharth Upadhyay | Additional Director | 11-Aug-2023 | Current |
| Kaushik Natesan | Director | 08-Apr-2020 | Current |
Financial Performance and Corporate Structure Insights of Chethana Pharma Distributors.
Chethana Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.82% increase. The company also saw a substantial improvement in profitability, with a 26.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chethana Pharma Distributors?
In 2023, Chethana Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chirag Medicare Solutions Private LimitedActive 5 years 8 monthsPraveen and Siddharth Upadhyay are mutual person
- Avenues Pharma Distributors Private LimitedActive 5 years 8 months
Siddharth Upadhyay is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chethana Pharma Distributors?
Chethana Pharma Distributors has a workforce of 27 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chethana Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chethana Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
